164 related articles for article (PubMed ID: 34980540)
1. Metabolic Syndrome and Risk of Breast Cancer by Molecular Subtype: Analysis of the MEND Study.
Akinyemiju T; Oyekunle T; Salako O; Gupta A; Alatise O; Ogun G; Adeniyi A; Deveaux A; Hall A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; Muehlbauer MJ; Newgard CB; ; Daramola A
Clin Breast Cancer; 2022 Jun; 22(4):e463-e472. PubMed ID: 34980540
[TBL] [Abstract][Full Text] [Related]
2. Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study.
Gupta A; Oyekunle T; Salako O; Daramola A; Alatise O; Ogun G; Adeniyi A; Deveaux A; Saraiya V; Hall A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; Muehlbauer MJ; Newgard CB; ; Akinyemiju T
Oncotarget; 2021 Jun; 12(13):1230-1242. PubMed ID: 34194621
[TBL] [Abstract][Full Text] [Related]
3. Association of body composition with odds of breast cancer by molecular subtype: analysis of the Mechanisms for Established and Novel Risk Factors for Breast Cancer in Nigerian Women (MEND) study.
Akinyemiju T; Jones K; Gupta A; Oyekunle T; Saraiya V; Deveaux A; Salako O; Hall A; Alatise O; Ogun G; Adeniyi A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; ; Daramola A
BMC Cancer; 2021 Sep; 21(1):1051. PubMed ID: 34563146
[TBL] [Abstract][Full Text] [Related]
4. Association of lipid profile biomarkers with breast cancer by molecular subtype: analysis of the MEND study.
Gupta A; Saraiya V; Deveaux A; Oyekunle T; Jackson KD; Salako O; Daramola A; Hall A; Alatise O; Ogun G; Adeniyi A; Ayandipo O; Olajide T; Olasehinde O; Arowolo O; Adisa A; Afuwape O; Olusanya A; Adegoke A; Tollefsbol TO; Arnett D; Muehlbauer MJ; Newgard CB; ; Akinyemiju T
Sci Rep; 2022 Jun; 12(1):10631. PubMed ID: 35739205
[TBL] [Abstract][Full Text] [Related]
5. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
Motoki AH; Buttros DAB; Gaspar AL; Almeida-Filho BS; Carvalho-Pessoa E; Vespoli HDL; Nahas-Neto J; Nahas EAP
Clin Breast Cancer; 2022 Feb; 22(2):e253-e261. PubMed ID: 34465534
[TBL] [Abstract][Full Text] [Related]
6. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study.
Brouckaert O; Rudolph A; Laenen A; Keeman R; Bolla MK; Wang Q; Soubry A; Wildiers H; Andrulis IL; Arndt V; Beckmann MW; Benitez J; Blomqvist C; Bojesen SE; Brauch H; Brennan P; Brenner H; Chenevix-Trench G; Choi JY; Cornelissen S; Couch FJ; Cox A; Cross SS; Czene K; Eriksson M; Fasching PA; Figueroa J; Flyger H; Giles GG; González-Neira A; Guénel P; Hall P; Hollestelle A; Hopper JL; Ito H; Jones M; Kang D; ; Knight JA; Kosma VM; Li J; Lindblom A; Lilyquist J; Lophatananon A; Mannermaa A; Manoukian S; Margolin S; Matsuo K; Muir K; Nevanlinna H; Peterlongo P; Pylkäs K; Saajrang S; Seynaeve C; Shen CY; Shu XO; Southey MC; Swerdlow A; Teo SH; Tollenaar RAEM; Truong T; Tseng CC; van den Broek AJ; van Deurzen CHM; Winqvist R; Wu AH; Yip CH; Yu JC; Zheng W; Milne RL; Pharoah PDP; Easton DF; Schmidt MK; Garcia-Closas M; Chang-Claude J; Lambrechts D; Neven P
Breast Cancer Res; 2017 Nov; 19(1):119. PubMed ID: 29116004
[TBL] [Abstract][Full Text] [Related]
7. The distribution of reproductive risk factors disclosed the heterogeneity of receptor-defined breast cancer subtypes among Tanzanian women.
Rweyemamu LP; Akan G; Adolf IC; Magorosa EP; Mosha IJ; Dharsee N; Namkinga LA; Lyantagaye SL; Nateri AS; Atalar F
BMC Womens Health; 2021 Dec; 21(1):423. PubMed ID: 34930226
[TBL] [Abstract][Full Text] [Related]
8. Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.
Agresti R; Meneghini E; Baili P; Minicozzi P; Turco A; Cavallo I; Funaro F; Amash H; Berrino F; Tagliabue E; Sant M
Breast Cancer Res Treat; 2016 May; 157(1):179-89. PubMed ID: 27117160
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and gallstone disease.
Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
[TBL] [Abstract][Full Text] [Related]
10. Examining the prevalence of metabolic syndrome among overweight/obese African-American breast cancer survivors vs. matched non-cancer controls.
Sheean P; Liang H; Schiffer L; Arroyo C; Stolley M
J Cancer Surviv; 2017 Feb; 11(1):102-110. PubMed ID: 27562474
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
Yuan Y; Pan K; Mortimer J; Chlebowski RT; Luo J; Yan JE; Yost SE; Kroenke CH; Adams-Campbell L; Nassir R; Sun Y; Shadyab AH; Vitolins MZ; Saquib N; Wild RA; Manson JE; Nelson RA
Cancer; 2021 May; 127(10):1658-1667. PubMed ID: 33476042
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and outcomes following early-stage breast cancer.
Calip GS; Malone KE; Gralow JR; Stergachis A; Hubbard RA; Boudreau DM
Breast Cancer Res Treat; 2014 Nov; 148(2):363-77. PubMed ID: 25301086
[TBL] [Abstract][Full Text] [Related]
13. Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women.
Crispo A; Montella M; Buono G; Grimaldi M; D'Aiuto M; Capasso I; Esposito E; Amore A; Nocerino F; Augustin LS; Giudice A; Di Bonito M; Giuliano M; Forestieri V; De Laurentiis M; Rinaldo M; Ciliberto G; De Placido S; Arpino G
Curr Res Transl Med; 2016; 64(1):15-20. PubMed ID: 27140595
[TBL] [Abstract][Full Text] [Related]
14. Association between Metabolic Syndrome Risk Factors and Immunohistochemical Profile in Women with Breast Cancer.
Danesh H; Anbiaei R; Ziamajidi N; Farhadian M; Barartabar Z; Abbasalipourkabir R
Iran J Med Sci; 2023 Sep; 48(5):456-464. PubMed ID: 37786471
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G
Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397
[TBL] [Abstract][Full Text] [Related]
16. Associations between smoking, components of metabolic syndrome and lipoprotein particle size.
Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH
BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807
[TBL] [Abstract][Full Text] [Related]
17. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study.
Kittiskulnam P; Thokanit NS; Katavetin P; Susanthitaphong P; Srisawat N; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
PLoS One; 2018; 13(5):e0196332. PubMed ID: 29742114
[TBL] [Abstract][Full Text] [Related]
18. The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis.
Zhao P; Xia N; Zhang H; Deng T
Obes Facts; 2020; 13(4):384-396. PubMed ID: 32698183
[TBL] [Abstract][Full Text] [Related]
19. Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis.
Mao X; Omeogu C; Karanth S; Joshi A; Meernik C; Wilson L; Clark A; Deveaux A; He C; Johnson T; Barton K; Kaplan S; Akinyemiju T
BMC Cancer; 2023 Jul; 23(1):644. PubMed ID: 37430191
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and breast cancer: a dangerous association for postmenopausal women.
Palmiero P; Maiello M; Cecere A; Ciccone MM
Acta Biomed; 2021 Sep; 92(4):e2021177. PubMed ID: 34487081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
